{"nctId":"NCT01347008","briefTitle":"Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis","startDateStruct":{"date":"2011-04"},"conditions":["Scleroderma, Systemic","Scleroderma, Diffuse","Scleroderma, Limited","Raynaud Phenomenon"],"count":41,"armGroups":[{"label":"Sildenafil citrate","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Sildenafil citrate"]},{"label":"Sugar pill","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo (Sugar pill)"]}],"interventions":[{"name":"Sildenafil citrate","otherNames":["Sildenafil citrate, EMS Sigma Pharma, Ltd, Brazil"]},{"name":"Placebo (Sugar pill)","otherNames":["Placebo"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Systemic sclerosis according to the classification criteria of the American College of Rheumatology (1980) with no more than 4 years since diagnosis\n* Early systemic sclerosis as defined by LeRoy and Medsger (2001)\n* 6 or more Raynaud's crisis per week\n* Written informed consent provided by the subjects prior to initiating study procedures\n\nExclusion Criteria:\n\n* Smoking\n* Peripheral or central vasculopathy other than Systemic sclerosis\n* Uncontrolled Diabetes\n* Liver disease\n* Pregnant or lactating woman\n* Current use of cyclosporin, prostanoids, bosentan or any PDE-5 inhibitors (including current Sildenafil use during randomization)\n* History of stroke, myocardial infarction or life threatening cardiac condition within the last 6 months\n* History of surgical sympathectomy\n* Systolic blood pressure \\< 85mm Hg\n* History of scleroderma renal crisis\n* Known hypersensitivity to Sildenafil or any of the excipients\n* History of Retinitis Pigmentosa\n* Current use of Nitrates","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Digital Skin Microvascular Blood Flow Measured by Laser Doppler Imaging (LDI) Before Cold Stimulus","description":"Finger blood flow of the four medial fingers, measured by laser Doppler imaging and expressed in arbitrary perfusion units (p.u.).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"260.0","spread":"108.0"},{"groupId":"OG001","value":"246.3","spread":"122.6"}]}]}]},{"type":"PRIMARY","title":"Digital Skin Microvascular Blood Flow Measured by Laser Doppler Imaging (LDI) After Cold Stimulus.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"257.7","spread":"123.3"},{"groupId":"OG001","value":"220.5","spread":"119.9"}]}]}]},{"type":"SECONDARY","title":"Daily Frequency of Raynaud's Phenomenon Attacks","description":"Daily frequency of RP attacks as self registered in a 1-week diary. Any episode of pallor or cyanosis of the hand/fingers was considered as a RP attack, and patients were supposed to register the daily amount of such episodes on a 1-week diary, previously to the medical visit.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.9","spread":"2.4"},{"groupId":"OG001","value":"1.7","spread":"2.2"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":21},"commonTop":["Headache"]}}}